Skip to main content

Dr. Danko Martincic, MD

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
30
In the NPI registry since
2006
Medicare patients seen, 2024
474

Licensed in Washington since 2006, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    ID license MC-0445 · WA license MD00046391 (first issued 2006; active)
  • Hematology (Internal Medicine) Physician
    ID license MC-0445
  • Medical Oncology Physician
    ID license MC-0445

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
474
Services billed
315,005
Patients’ average age
74
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, nivolumab, 1 mg46,09024
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)22,95020
Injection, pembrolizumab, 1 mg20,20021
Injection, paclitaxel, 1 mg6,88816
Injection, dexamethasone sodium phosphate, 1 mg6,86288
Injection, fosaprepitant, 1 mg5,40012
Injection, denosumab, 1 mg5,34020
Injection, ipilimumab, 1 mg3,16011
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg2,91012
Injection, palonosetron hcl, 25 mcg2,78050

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 36 companies reported 226 payments worth $189,966 in total to this clinician.

By type
Compensation for services other than consulting (speaking, faculty)$122,880
Consulting Fee$45,820
Travel and Lodging$15,896
Food and Beverage$5,271
Education$99.00

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jun 6, 2025E.r. Squibb & Sons, L.l.c.
Jun 6, 2025
Compensation for services other than consulting (speaking, faculty)
REBLOZYL · Hematology
$7,280
Mar 25, 2025E.r. Squibb & Sons, L.l.c.
Mar 25, 2025
Compensation for services other than consulting (speaking, faculty)
REBLOZYL · Hematology
$7,280
May 30, 2025E.r. Squibb & Sons, L.l.c.
May 30, 2025
Compensation for services other than consulting (speaking, faculty)
OPDIVO · Oncology
$7,280
May 20, 2025AstraZeneca Pharmaceuticals LP
May 20, 2025
Compensation for services other than consulting (speaking, faculty)
ENHERTU · Oncology
Company’s descriptionSpeaker Fee
$6,030
Apr 24, 2025AstraZeneca Pharmaceuticals LP
Apr 24, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$6,030
May 6, 2025Pfizer Inc.
May 6, 2025
Consulting Fee
ADCETRIS · ONCOLOGY
$5,820
Nov 7, 2025Merck Sharp & Dohme LLC
Nov 7, 2025
Compensation for services other than consulting (speaking, faculty)
KEYTRUDA · ONCOLOGY
$5,760
Nov 14, 2025Merck Sharp & Dohme LLC
Nov 14, 2025
Compensation for services other than consulting (speaking, faculty)
KEYTRUDA · ONCOLOGY
$5,760
Jun 16, 2025E.r. Squibb & Sons, L.l.c.
Jun 16, 2025
Compensation for services other than consulting (speaking, faculty)
OPDIVO · Oncology
$5,460
Apr 2, 2025Pfizer Inc.
Apr 2, 2025
Consulting Fee
PADCEV · ONCOLOGY
$5,400
All 85 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Nov 24, 2025Astellas Pharma US Inc
Nov 24, 2025
Consulting Fee
Padcev · Oncology
$300
Nov 17, 2025Pfizer Inc.
Nov 17, 2025
Consulting Fee
ADCETRIS · ONCOLOGY
$4,000
Nov 14, 2025Merck Sharp & Dohme LLC
Nov 14, 2025
Compensation for services other than consulting (speaking, faculty)
KEYTRUDA · ONCOLOGY
$5,760
Nov 14, 2025Pfizer Inc.
Nov 14, 2025
Consulting Fee
ADCETRIS · ONCOLOGY
$1,300
Nov 14, 2025Pfizer Inc.
Nov 14, 2025
Consulting Fee
ADCETRIS · ONCOLOGY
$325
Nov 14, 2025Merck Sharp & Dohme LLC
Nov 14, 2025
Travel and Lodging
KEYTRUDA · ONCOLOGY · travel to Lewiston, ID
$150
Nov 13, 2025Merck Sharp & Dohme LLC
Nov 13, 2025
Travel and Lodging
KEYTRUDA · ONCOLOGY · travel to Moscow, ID
$150
Nov 12, 2025Regeneron Healthcare Solutions, Inc.
Nov 12, 2025
Compensation for services other than consulting (speaking, faculty)
LIBTAYO · ONCOLOGY
$945
Nov 7, 2025Merck Sharp & Dohme LLC
Nov 7, 2025
Compensation for services other than consulting (speaking, faculty)
KEYTRUDA · ONCOLOGY
$5,760
Nov 4, 2025Merck Sharp & Dohme LLC
Nov 4, 2025
Travel and Lodging
KEYTRUDA · ONCOLOGY · travel to Lewiston, ID · in-kind
$1,008
Oct 30, 2025Merck Sharp & Dohme LLC
Oct 30, 2025
Travel and Lodging
KEYTRUDA · ONCOLOGY · travel to Moscow, ID · in-kind
$1,464
Oct 24, 2025Regeneron Healthcare Solutions, Inc.
Oct 24, 2025
Compensation for services other than consulting (speaking, faculty)
LIBTAYO · ONCOLOGY
$923
Sep 29, 2025Astellas Pharma US Inc
Sep 29, 2025
Consulting Fee
Padcev · Oncology
$750
Sep 17, 2025E.r. Squibb & Sons, L.l.c.
Sep 17, 2025
Consulting Fee$455
Aug 22, 2025Daiichi Sankyo Inc.
Aug 22, 2025
Consulting Fee
Enhertu · ONCOLOGY
$670
Aug 19, 2025AstraZeneca Pharmaceuticals LP
Aug 19, 2025
Consulting Fee$2,680
Aug 12, 2025E.r. Squibb & Sons, L.l.c.
Aug 12, 2025
Compensation for services other than consulting (speaking, faculty)
OPDIVO · Oncology
$3,640
Jul 31, 2025AstraZeneca Pharmaceuticals LP
Jul 31, 2025
Travel and Lodging
ENHERTU · Oncology · travel to Bozeman, MT · in-kind
Company’s descriptionSpeaker Expenses
$35.00
Jul 21, 2025E.r. Squibb & Sons, L.l.c.
Jul 21, 2025
Consulting Fee$1,820
Jul 16, 2025AstraZeneca Pharmaceuticals LP
Jul 16, 2025
Consulting Fee$670
Jul 15, 2025E.r. Squibb & Sons, L.l.c.
Jul 15, 2025
Consulting Fee$455
Jul 5, 2025Astellas Pharma US Inc
Jul 5, 2025
Compensation for services other than consulting (speaking, faculty)
Padcev · Oncology
$856
Jun 16, 2025E.r. Squibb & Sons, L.l.c.
Jun 16, 2025
Compensation for services other than consulting (speaking, faculty)
OPDIVO · Oncology
$5,460
Jun 10, 2025Daiichi Sankyo Inc.
Jun 10, 2025
Compensation for services other than consulting (speaking, faculty)
Enhertu · ONCOLOGY
$4,020
Jun 6, 2025E.r. Squibb & Sons, L.l.c.
Jun 6, 2025
Compensation for services other than consulting (speaking, faculty)
REBLOZYL · Hematology
$7,280
Jun 6, 2025AstraZeneca Pharmaceuticals LP
Jun 6, 2025
Compensation for services other than consulting (speaking, faculty)
ENHERTU · Oncology
Company’s descriptionSpeaker Fee
$5,360
Jun 3, 2025AstraZeneca Pharmaceuticals LP
Jun 3, 2025
Travel and Lodging
ENHERTU · Oncology · travel to Bend, OR · in-kind
Company’s descriptionSpeaker Expenses
$1,001
Jun 3, 2025AstraZeneca Pharmaceuticals LP
Jun 3, 2025
Travel and Lodging
ENHERTU · Oncology · travel to Bend, OR · in-kind
Company’s descriptionSpeaker Expenses
$330
May 30, 2025E.r. Squibb & Sons, L.l.c.
May 30, 2025
Compensation for services other than consulting (speaking, faculty)
OPDIVO · Oncology
$7,280
May 30, 2025AstraZeneca Pharmaceuticals LP
May 30, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$5,360
May 28, 2025AstraZeneca Pharmaceuticals LP
May 28, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$4,020
May 28, 2025E.r. Squibb & Sons, L.l.c.
May 28, 2025
Travel and Lodging
OPDIVO · Oncology · travel to Wenatchee, WA
$1,431
May 28, 2025Seagen Inc.
May 28, 2025
Education
in-kind
$99.00
May 20, 2025AstraZeneca Pharmaceuticals LP
May 20, 2025
Compensation for services other than consulting (speaking, faculty)
ENHERTU · Oncology
Company’s descriptionSpeaker Fee
$6,030
May 20, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
May 20, 2025
Consulting Fee$870
May 20, 2025E.r. Squibb & Sons, L.l.c.
May 20, 2025
Travel and Lodging
REBLOZYL · Hematology · travel to Seattle, WA
$587
May 20, 2025E.r. Squibb & Sons, L.l.c.
May 20, 2025
Consulting Fee$455
May 20, 2025E.r. Squibb & Sons, L.l.c.
May 20, 2025
Travel and Lodging
REBLOZYL · Hematology · travel to Seattle, WA
$392
May 15, 2025E.r. Squibb & Sons, L.l.c.
May 15, 2025
Consulting Fee$1,820
May 15, 2025E.r. Squibb & Sons, L.l.c.
May 15, 2025
Consulting Fee$1,820
May 15, 2025AstraZeneca Pharmaceuticals LP
May 15, 2025
Travel and Lodging
ENHERTU · Oncology · travel to Medford, OR · in-kind
Company’s descriptionSpeaker Expenses
$576
May 15, 2025AstraZeneca Pharmaceuticals LP
May 15, 2025
Travel and Lodging
ENHERTU · Oncology · travel to Medford, OR · in-kind
Company’s descriptionSpeaker Expenses
$189
May 13, 2025AstraZeneca Pharmaceuticals LP
May 13, 2025
Consulting Fee
IMFINZI · Oncology
$1,675
May 8, 2025E.r. Squibb & Sons, L.l.c.
May 8, 2025
Travel and Lodging
OPDIVO · Oncology · travel to Tacoma, WA
$633
May 8, 2025E.r. Squibb & Sons, L.l.c.
May 8, 2025
Travel and Lodging
OPDIVO · Oncology · travel to Tacoma, WA
$422
May 7, 2025AstraZeneca Pharmaceuticals LP
May 7, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$3,350
May 6, 2025Pfizer Inc.
May 6, 2025
Consulting Fee
ADCETRIS · ONCOLOGY
$5,820
May 5, 2025E.r. Squibb & Sons, L.l.c.
May 5, 2025
Compensation for services other than consulting (speaking, faculty)
REBLOZYL · Hematology
$3,185
Apr 26, 2025Pfizer Inc.
Apr 26, 2025
Travel and Lodging
ADCETRIS · ONCOLOGY · travel to Dallas, TX · in-kind
$679
Apr 26, 2025Pfizer Inc.
Apr 26, 2025
Travel and Lodging
ADCETRIS · ONCOLOGY · travel to Dallas, TX · in-kind
$327
Apr 25, 2025Regeneron Healthcare Solutions, Inc.
Apr 25, 2025
Compensation for services other than consulting (speaking, faculty)
LIBTAYO · ONCOLOGY
$5,272
Apr 25, 2025Regeneron Healthcare Solutions, Inc.
Apr 25, 2025
Travel and Lodging
LIBTAYO · ONCOLOGY · travel to TACOMA, WA · in-kind
$666
Apr 24, 2025AstraZeneca Pharmaceuticals LP
Apr 24, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$6,030
Apr 10, 2025AstraZeneca Pharmaceuticals LP
Apr 10, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$300
Apr 9, 2025AstraZeneca Pharmaceuticals LP
Apr 9, 2025
Compensation for services other than consulting (speaking, faculty)
ENHERTU · Oncology
Company’s descriptionSpeaker Fee
$5,360
Apr 8, 2025Regeneron Healthcare Solutions, Inc.
Apr 8, 2025
Travel and Lodging
LIBTAYO · ONCOLOGY · travel to WENATCHEE, WA · in-kind
$237
Apr 7, 2025AstraZeneca Pharmaceuticals LP
Apr 7, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$3,350
Apr 3, 2025AstraZeneca Pharmaceuticals LP
Apr 3, 2025
Travel and Lodging
ENHERTU · Oncology · travel to Portland, OR · in-kind
Company’s descriptionSpeaker Expenses
$701
Apr 3, 2025AstraZeneca Pharmaceuticals LP
Apr 3, 2025
Travel and Lodging
ENHERTU · Oncology · travel to Portland, OR · in-kind
Company’s descriptionSpeaker Expenses
$363
Apr 2, 2025Pfizer Inc.
Apr 2, 2025
Consulting Fee
PADCEV · ONCOLOGY
$5,400
Apr 1, 2025Daiichi Sankyo Inc.
Apr 1, 2025
Compensation for services other than consulting (speaking, faculty)
Enhertu · ONCOLOGY
$5,360
Apr 1, 2025Regeneron Healthcare Solutions, Inc.
Apr 1, 2025
Compensation for services other than consulting (speaking, faculty)
LIBTAYO · ONCOLOGY
$5,272
Mar 31, 2025Pfizer Inc.
Mar 31, 2025
Travel and Lodging
PADCEV · ONCOLOGY · travel to San Diego, CA · in-kind
$540
Mar 31, 2025Pfizer Inc.
Mar 31, 2025
Travel and Lodging
PADCEV · ONCOLOGY · travel to San Diego, CA · in-kind
$528
Mar 31, 2025Pfizer Inc.
Mar 31, 2025
Travel and Lodging
PADCEV · ONCOLOGY · travel to San Diego, CA · in-kind
$393
Mar 31, 2025Regeneron Healthcare Solutions, Inc.
Mar 31, 2025
Travel and Lodging
LIBTAYO · ONCOLOGY · travel to TACOMA, WA · in-kind
$217
Mar 25, 2025E.r. Squibb & Sons, L.l.c.
Mar 25, 2025
Compensation for services other than consulting (speaking, faculty)
REBLOZYL · Hematology
$7,280
Mar 13, 2025AstraZeneca Pharmaceuticals LP
Mar 13, 2025
Compensation for services other than consulting (speaking, faculty)
ENHERTU · Oncology
Company’s descriptionSpeaker Fee
$5,360
Mar 13, 2025Pfizer Inc.
Mar 13, 2025
Consulting Fee
ADCETRIS · ONCOLOGY
$5,125
Mar 5, 2025AstraZeneca Pharmaceuticals LP
Mar 5, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$5,360
Mar 4, 2025E.r. Squibb & Sons, L.l.c.
Mar 4, 2025
Compensation for services other than consulting (speaking, faculty)
REBLOZYL · Hematology
$3,640
Mar 4, 2025E.r. Squibb & Sons, L.l.c.
Mar 4, 2025
Travel and Lodging
REBLOZYL · Hematology · travel to Everett, WA
$438
Mar 4, 2025E.r. Squibb & Sons, L.l.c.
Mar 4, 2025
Travel and Lodging
REBLOZYL · Hematology · travel to Everett, WA
$342
Feb 27, 2025E.r. Squibb & Sons, L.l.c.
Feb 27, 2025
Consulting Fee$1,820
Feb 26, 2025AstraZeneca Pharmaceuticals LP
Feb 26, 2025
Travel and Lodging
travel to Tigard, OR · in-kind
Company’s descriptionSpeaker Expenses
$813
Feb 26, 2025AstraZeneca Pharmaceuticals LP
Feb 26, 2025
Travel and Lodging
travel to Tigard, OR · in-kind
Company’s descriptionSpeaker Expenses
$31.08
Feb 25, 2025E.r. Squibb & Sons, L.l.c.
Feb 25, 2025
Consulting Fee$1,820
Feb 20, 2025Daiichi Sankyo Inc.
Feb 20, 2025
Consulting Fee
Enhertu · ONCOLOGY
$1,665
Feb 20, 2025Daiichi Sankyo Inc.
Feb 20, 2025
Consulting Fee
Enhertu · ONCOLOGY
$670
Feb 20, 2025Daiichi Sankyo Inc.
Feb 20, 2025
Consulting Fee
Enhertu · ONCOLOGY
$555
Jan 29, 2025Pfizer Inc.
Jan 29, 2025
Consulting Fee
PADCEV · ONCOLOGY
$2,880
Jan 22, 2025AstraZeneca Pharmaceuticals LP
Jan 22, 2025
Compensation for services other than consulting (speaking, faculty)
IMFINZI · Oncology
Company’s descriptionSpeaker Fee
$300
Jan 18, 2025Pfizer Inc.
Jan 18, 2025
Travel and Lodging
ADCETRIS · ONCOLOGY · travel to Portland, OR · in-kind
$707
Jan 18, 2025Pfizer Inc.
Jan 18, 2025
Travel and Lodging
ADCETRIS · ONCOLOGY · travel to Portland, OR · in-kind
$547
Jan 9, 2025Regeneron Healthcare Solutions, Inc.
Jan 9, 2025
Compensation for services other than consulting (speaking, faculty)
LIBTAYO · ONCOLOGY
$768

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Idaho →

Industry-funded research

Named as a principal investigator on 14 industry-funded studies in 2025, from 8 companies. The companies reported $449,763 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hematology & Oncology clinicians in Post Falls

Sources

NPI registry (CMS NPPES, November 2026; record last updated August 25, 2023), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1124071592. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.